ECM
STJ

Endurant Capital Management’s St Jude Medical STJ Stock Holding History

Endurant Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-120,777
Closed -$9.69M – 104
2016
Q4 		$9.69M Buy
120,777
+11,729
+11% +$931K 4% 3
2016
Q3 		$8.7M Sell
109,048
-12,234
-10% -$988K 3.22% 7
2016
Q2 		$9.46M Sell
121,282
-24,600
-17% -$1.75M 3.16% 10
2016
Q1 		$8.02M Buy
145,882
+19,001
+15% +$1.04M 2.6% 11
2015
Q4 		$7.84M Sell
126,881
-118,645
-48% -$7.48M 2.62% 12
2015
Q3 		$15.5M Buy
245,526
+82,112
+50% +$5.86M 5.17% 1
2015
Q2 		$11.9M Buy
163,414
+55,883
+52% +$4.04M 3.52% 7
2015
Q1 		$7.03M Buy
107,531
+61,800
+135% +$4.11M 2.32% 10
2014
Q4 		$2.97M Buy
+45,731
New +$2.95M 1.17% 26

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Endurant Capital Management's STJ Position: Q1 2017 in Review

Endurant Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 120,777 shares — an estimated $9.69M sold.

Endurant Capital Management first reported a position in STJ in Q4 2014 and held it in 9 quarters. The position peaked at $15.5M in Q3 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Endurant Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Endurant Capital Management sold 120,777 St Jude Medical shares in Q1 2017, an estimated $9.69M.
  • Endurant Capital Management first reported a position in St Jude Medical in Q4 2014 and held it in 9 quarters.
  • Endurant Capital Management's St Jude Medical position peaked at $15.5M in Q3 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Endurant Capital Management's 13F filing for Q1 2017, filed 15 May 2017.